Evidence map›Paper›PMID 38473833›Full record

ArticleInternational journal of molecular sciences2024

Changes in the Concentrations of Proangiogenic Cytokines in Human Brain Glioma and Acute Lymphoblastic Leukemia.

Lukasz Oldak, Zuzanna Zielinska, Patrycja Milewska, Sylwia Chludzinska-Kasperuk, Eryk Latoch, Katarzyna Konończuk, Maryna Krawczuk-Rybak, Aleksandra Starosz, Kamil Grubczak, Joanna Reszeć and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Lukasz OldakBioanalysis Laboratory, Faculty of Chemistry, University of Bialystok, Ciolkowskiego 1K, 15-245 Bialystok, Poland.ORCID 0000-0003-1829-7466
Zuzanna ZielinskaDoctoral School of Exact and Natural Science, Faculty of Chemistry, University of Bialystok, Ciolkowskiego 1K, 15-245 Bialystok, Poland.ORCID 0000-0002-8515-9840
Patrycja MilewskaBiobank, Medical University of Bialystok, Waszyngtona 13, 15-269 Bialystok, Poland.
Sylwia Chludzinska-KasperukBiobank, Medical University of Bialystok, Waszyngtona 13, 15-269 Bialystok, Poland.
Eryk LatochDepartment of Pediatric Oncology and Hematology, Medical University of Bialystok, 15-274 Bialystok, Poland.ORCID 0000-0002-7667-7953
Katarzyna KonończukDepartment of Pediatric Oncology and Hematology, Medical University of Bialystok, 15-274 Bialystok, Poland.ORCID 0000-0003-0540-8040
Maryna Krawczuk-RybakDepartment of Pediatric Oncology and Hematology, Medical University of Bialystok, 15-274 Bialystok, Poland.
Aleksandra StaroszDepartment of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Waszyngtona 13, 15-269 Bialystok, Poland.ORCID 0000-0003-1084-5747
Kamil GrubczakDepartment of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Waszyngtona 13, 15-269 Bialystok, Poland.ORCID 0000-0002-6828-6397
Joanna ReszećBiobank, Medical University of Bialystok, Waszyngtona 13, 15-269 Bialystok, Poland.
Ewa GorodkiewiczBioanalysis Laboratory, Faculty of Chemistry, University of Bialystok, Ciolkowskiego 1K, 15-245 Bialystok, Poland.
Medical University of Białystok · PLUniversity of Białystok · PL

Funding

Ministry of Science and Higher Education BST-162
6 · The paper itself

Abstract

Acute lymphoblastic leukemia (ALL) and glioma are some of the most common malignancies, with ALL most often affecting children and glioma affecting adult men. Proangiogenic cytokines and growth factors play an important role in the development of both of these tumors. Glioma is characterized by an extremely extensive network of blood vessels, which continues to expand mainly in the process of neoangiogenesis, the direct inducers of which are cytokines from the family of vascular endothelial growth factors, i.e., vascular endothelial growth factor (VEGF-A) and its receptor vascular endothelial growth factor receptor 2 (VEGF-R2), as well as a cytokine from the fibroblast growth factor family, fibroblast growth factor 2 (FGF-2 or bFGF). Growth factors are known primarily for their involvement in the progression and development of solid tumors, but there is evidence that local bone marrow angiogenesis and increased blood vessel density are also present in hematological malignancies, including leukemias. The aim of this study was to examine changes in the concentrations of VEGF-A, VEGF-R2, and FGF-2 (with a molecular weight of 17 kDa) in a group of patients divided into specific grades of malignancy (glioma) and a control group; changes of VEGF-A and FGF-2 concentrations in childhood acute lymphoblastic leukemia and a control group; and to determine correlations between the individual proteins as well as the influence of the patient's age, diet, and other conditions that may place the patient in the risk group. During the statistical analysis, significant differences in concentrations were found between the patient and control groups in samples from people with diagnosed glioma and from children with acute lymphoblastic leukemia, but in general, there are no significant differences in the concentrations of VEGF-A, VEGF-R2, and FGF-2 between different grades of glioma malignancy. Among individuals treated for glioma, there was no significant impact from the patient's gender and age, consumption of food from plastic packaging, frequency of eating vegetables and fruit, smoking of tobacco products, the intensity of physical exercise, or the general condition of the body (Karnofsky score) on the concentrations of the determined cytokines and receptor. The listed factors do not bring about an actual increase in the risk of developing brain glioma.

Indexed as

GliomaPrecursor Cell Lymphoblastic Leukemia-LymphomaAdultBrainChildCytokinesFibroblast Growth Factor 2HumansMaleVascular Endothelial Growth Factor AVascular Endothelial Growth FactorsCytokinesFibroblast Growth Factor 2Vascular Endothelial Growth Factor AVascular Endothelial Growth Factorsbiomarkerschildhood acute lymphoblastic leukemiaFGF-2gliomaVEGF-AVEGF-R2

Identifiers

PMID38473833
PMCPMC10931821
OpenAlexW4392124888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.